Hørsholm – June 7, 2007: 7TM Pharma A/S has raised DKK 123 million (EUR 16.5 million) in a new financing round. The financing round included SR One Limited (SR One), who led the investment with strong support from the company’s existing investors. SR One is GlaxoSmithKline’s (GSK) independent corporate health care venture fund.
